One of the many routes proposed for the cellular inactivation of endogenous nitric oxide (NO) is by the cytochrome c oxidase of the mitochondrial respiratory chain. We have studied this possibility in human embryonic kidney cells engineered to generate controlled amounts of NO. We have used visible light spectroscopy to monitor continuously the redox state of cytochrome c oxidase in an oxygentight chamber, at the same time as which we measure cell respiration and the concentrations of oxygen and NO. Pharmacological manipulation of cytochrome c oxidase indicates that this enzyme, when it is in turnover and in its oxidized state, inactivates physiological amounts of NO, thus regulating its intra-and extracellular concentrations. This inactivation is prevented by blocking the enzyme with inhibitors, including NO. Furthermore, when cells generating low concentrations of NO respire toward hypoxia, the redox state of cytochrome c oxidase changes from oxidized to reduced, leading to a decrease in NO inactivation. The resultant increase in NO concentration could explain hypoxic vasodilation.
D
espite much research on its metabolic fate, the way in which the concentration of nitric oxide (NO) is regulated in cells and tissues is at present unresolved. Many routes for its inactivation have been discussed, including interaction with superoxide ions (1), hemoglobin (2) (3) (4) or myoglobin (5), accelerated autoxidation favored by partition within cell membranes (6) , and interactions with free radicals derived from eicosanoid lipoxygenase (7), cyclo-oxygenase (8) , different peroxidases (9) , or catalase (10) . Interactions with a flavohemoglobin-like NO dioxygenase (11) (12) (13) or with an unknown protein (14) , and simple partitioning within mitochondrial membranes (15) , have also been suggested.
Before the discovery of NO as a biological mediator (16) it had been shown that isolated cytochrome c oxidase, the terminal enzyme in the mitochondrial electron transport chain, catalyzes both the oxidation and reduction of NO (17) . More recent evidence has suggested that cytochrome c oxidase may provide a metabolic route for NO, either by interaction of NO with the reduced enzyme, leading to the formation of N 2 O, (18, 19) or by interaction of NO with the oxidized enzyme, forming nitrite (NO 2 Ϫ ; 20, 21) . Although the NO reductase activity of the enzyme is too slow to constitute a physiological mechanism for the removal of NO (22) , there is strong evidence in favor of the oxidation of NO to NO 2 Ϫ both by the purified enzyme (23, 24) and by cells (25) . Nevertheless, the possibility that cytochrome c oxidase constitutes a significant metabolic route for NO remains controversial (26, 27) and has been directly challenged (28) .
Clarifying the route(s) of the cellular inactivation of NO will be important for a fuller understanding of its biological functions. We have therefore investigated the role of cytochrome c oxidase in the metabolic fate of NO by using our method based on visible light spectroscopy (see refs. [29] [30] [31] . This allows us to study cell respiration and the redox state of cytochrome c oxidase at the same time as which we monitor O 2 and NO concentrations in cells respiring toward hypoxia in an O 2 -tight chamber. In most of our studies, we have used a cell system engineered to express an NO synthase under the control of an inducible promoter (32, 33) . After induction, the amount of NO generated by this system depends on the concentration of substrate (L-arginine) added. Furthermore the synthesis and release of NO occur within the cells, thus avoiding the use of exogenously administered NO.
Our results indicate that cytochrome c oxidase provides a major route for the inactivation of endogenous NO when this enzyme is in its oxidized state. Furthermore, this inactivation only occurs when the enzyme is in turnover and when the concentration of NO is not sufficient to inhibit the enzyme completely. Cessation of this inactivation mechanism at low [O 2 ] may explain hypoxic vasodilation.
Results

Effect of Hypoxia on the Release of NO.
The addition of different concentrations of L-arginine at 70 M O 2 to induced Tet-iNOS-293 cells respiring toward hypoxia in the chamber led to a concentration-dependent release of NO that was maximal after the addition of 50 M L-arginine (Fig. 1) . The release induced by all concentrations of L-arginine was prevented by concomitant administration of a concentration of S-ethylisothiourea (S-EITU) sufficient to inhibit NO synthase (500 M; data not shown). At concentrations of L-arginine above 10 M, the release of NO occurred without a delay, reaching a maximum at Ϸ30 M O 2 and then declining as the [O 2 ] in the chamber fell below 20 M (Fig. 1 A) . In contrast, at concentrations of L-arginine below 10 M, the release of NO was at first gradual, followed by a peak that was not observed until the [O 2 ] fell below 20 M (Fig. 1B) . The lower the concentration of L-arginine, the lower was the [O 2 ] at which the peak of NO was observed (Fig.  1B) . The pattern of NO release at both high and low concentrations of L-arginine was unchanged when experiments were carried out in the presence of superoxide dismutase (500 units) administered immediately before the start of the experiment (data not shown).
Nitrite Reduction Does Not Contribute to the Release of NO in
Hypoxia. To determine the cause of the increase in NO release at low [O 2 ], we first established whether the NO might be coming from a source other than NO synthase. Nitric oxide generated by the cells and released into the extracellular fluid is mainly oxidized to NO 2 Ϫ (34). In our experiments, the release of NO led to a progressive accumulation of NO 2 Ϫ in the chamber (6.2 Ϯ 2.2 M per 10 7 cells in 15 min when 100 M L-arginine was added, n ϭ 3), which was proportional to the amount of L-arginine added and therefore to NO released. One possibility, therefore, is that the release of NO at low [O 2 ] was caused by the reduction of this accumulated NO 2 Ϫ back to NO, as has been suggested (35) . If this were the mechanism, then the peak of NO observed at low [O 2 ] would occur even at the higher concentrations of L-arginine and would be proportional to the amount of this substrate, which was not the case. Nevertheless, we carried out experiments in which a high concentration (100 M) of NO 2 Ϫ instead of Thus, all of the NO detected, including the peak observed at low 4A ) and a concentrationdependent release of NO (Fig. 4B) . To demonstrate the relationship between these two parameters we compared them both at the arbitrary time of 100 s after the addition of L-arginine. The percentage inactivation of NO for each concentration of KCN was calculated (see Experimental Procedures) and compared with the percentage reduction of the enzyme (Fig. 4C) The experiments above suggest that increasing the concentration of NO should progressively decrease its own inactivation by inhibiting and thus reducing cytochrome c oxidase. To demonstrate this we compared the release of NO produced by increasing concentrations of L-arginine in the presence or absence of 500 M KCN. The differences in NO release, again measured at 100 s after the addition of L-arginine, were used to estimate the percentage inactivation of NO for each concentration of L-arginine. Although the results calculated in this way grossly underestimate the phenomenon, they do show that increasing concentrations of NO progressively inhibit its inactivation by cytochrome c oxidase (85 Ϯ 11%, 48 Ϯ 2%, and 6 Ϯ 2% inactivation at 2.5, 10, and 100 M L-arginine, respectively).
We next decided to manipulate cytochrome c oxidase pharmacologically to determine the relationship between the redox state and turnover of the enzyme and its capacity to inactivate NO. We used N,N,NЈ,NЈ-tetramethyl-p-phenylenediamine (TMPD) and ascorbate to increase the electron flow in cytochrome c oxidase, increasing the turnover of the enzyme while also increasing its reduced state (see ref. 31 and Fig. 5 A Inset) . The addition of 180 M TMPD and 6 mM ascorbate increased the VO 2 from 12.9 Ϯ 1.5 to 23.3 Ϯ 1.2 M⅐min Ϫ1 per 10 7 cells and the turnover from 50-60 to 80-100 e Ϫ per second. Under these conditions there was less inactivation of NO (Fig. 5A) . The use of carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP, 1 M), however, which uncoupled the electron transport chain, increasing the VO 2 from 12.9 Ϯ 1.5 to 21.4 Ϯ 2.8 M⅐min Ϫ1 per 10 7 cells and the turnover from 50-60 to 80-100 e Ϫ per second without reducing cytochrome c oxidase (see Fig.  5A Insert) , actually increased the inactivation of NO generated from the same concentration of L-arginine (Fig. 5A ). Fig. 5B shows the effects of TMPD and FCCP on the percentage inactivation of the NO generated by 2.5, 10, and 100 M L-arginine. These experiments indicate that the turnover of cytochrome c oxidase and its redox state are responsible for the fine-tuning of cellular NO concentrations.
Discussion
By using a system that allows us to monitor a variety of parameters in cells respiring toward hypoxia, we have investigated the metabolic fate of NO. Nitric oxide was detected either by an electrode in the chamber where the cells were suspended or by the activity of soluble guanylate cyclase within the cells, giving an indication of the kinetics of NO once it had been generated by NO synthase.
Our results show that, in respiring cells, cytochrome c oxidase, in its oxidized state, constantly inactivates NO and thus regulates its intracellular concentration. This activity is prevented when the enzyme is inhibited (and therefore reduced) by KCN or NO itself or when it is reduced at low [O 2 ]. The experiments using TMPD and ascorbate, or FCCP, further demonstrate that increases in turnover leading to similar rates of O 2 consumption result in different inactivation rates of NO, depending on the redox state of the enzyme.
Thus, the metabolic fate of NO is determined by the subtle interplay between, on the one hand, the flux (i.e., change in concentration over time) of NO generated by NO synthase and, on the other hand, the redox state, turnover, and [O 2 ] at which cytochrome c oxidase is operating. Therefore, this is a finely tuned mechanism that regulates intracellular concentrations of NO, operates efficiently at physiological or near-physiological NO fluxes, and is likely to take precedence over any of the other mechanisms previously identified for the inactivation of NO (see the introduction). Nevertheless, the relative importance of the various inactivating mechanisms needs to be determined, preferably in systems in which the three key enzymes, namely, NO synthase, cytochrome c oxidase, and soluble guanylate cyclase, are allowed to interact in the processing of endogenously generated NO. The use of NO donors alone, with all its attendant pitfalls, is unlikely to provide significant new information in relation to these interactions.
Our results shed light on the possible operation of this system of enzymes in two particular situations. In the first situation, the [O 2 ] is not critical. We have previously demonstrated that increases in [NO] relative to [O 2 ] that are not yet sufficient to inhibit respiration reduce cytochrome c oxidase and that the recruitment of excess capacity of this enzyme is able to maintain O 2 consumption in the cell (31) . Only when the NO:O 2 ratio increases to a point at which this excess capacity is fully used does inhibition of respiration ensue. In this situation, the generation of NO will not be compromised because NO synthase will be operating at a noncritical [O 2 ] and therefore the main determinant of the [NO] in and outside the cell will be the varying capacity of cytochrome c oxidase to inactivate NO, the latter ceasing when the enzyme is fully inhibited. Thus, in situations in which a high rate of NO generation leads to inhibition of cytochrome c oxidase, one would expect a lack of inactivation of NO that may lead to nonphysiological interactions.
The second situation is one in which the [O 2 ] decreases to critical levels, such as occurs in our O 2 -tight chamber. The reported K m of NO synthase for O 2 varies widely, from 6-23 M (37) up to 135-400 M (38). However, in our hands S-EITU was able to inhibit NO release even when given at an [O 2 ] as low as 10 M, indicating that NO synthase remains active in the cells at very low [O 2 ]. This has been observed in other preparations (see ref. 39 ). Although we have not carried out detailed studies of the activity of NO synthase and the fluxes of NO it generates at low [O 2 ], one possible explanation for its activity in cells at this unexpectedly low [O 2 ] is that, as the inactivation of NO decreases at low [O 2 ], it inhibits respiration, thus diverting O 2 toward NO synthase in a process akin to that which we have described for the prolyl hydroxylases (40). The degree of inactivation was calculated as described in Experimental Procedures. (n ϭ 3). A two-way ANOVA followed by Tukey's multiple comparisons test showed that there were significant (P Ͻ 0.05) differences in NO inactivation among treatments (control, asc/TMPD, FCCP) and among L-arginine (2.5, 10, 100 M) concentrations.
In a similar manner, the reduction and therefore inhibition of cytochrome c oxidase at low [O 2 ] diverts the NO, which is now not inactivated, toward soluble guanylate cyclase and to other targets within and outside the cell. This would explain the release of NO that we observe at low [O 2 ]. The fate of the NO interacting with the now reduced cytochrome c oxidase remains an interesting question. Determining whether the enzyme shows any NO reductase activity in cells, or whether the NO remains attached to the enzyme in a semistable situation (see refs. 23 and 24), will further help our understanding of the responses of tissues to hypoxia.
Recently there has been a great deal of interest in the possibility that NO might be generated by sources other than directly from NO synthase. The most widely discussed suggestions are that S-nitrosated hemoglobin (SNO-Hb) releases Snitrosothiols during deoxygenation (41) or that hemoglobin is an allosteric regulated heme-based nitrite reductase that reduces NO 2 Ϫ to NO as hemoglobin deoxygenates (42) . Both of these mechanisms have been suggested to explain hypoxic vasodilation. Reduction of NO 2 Ϫ to NO by a variety of other mechanisms has also been proposed (35, (43) (44) (45) . Although our results do not directly challenge any of these interesting possibilities, they do show that the concentrations of locally generated NO are regulated by cytochrome c oxidase in an O 2 -dependent manner. The amount of available NO clearly increases at low [O 2 ] when the activity of cytochrome c oxidase decreases. This NO is detected by soluble guanylate cyclase, showing the interplay between the enzymes to regulate the concentration of NO. The NO that we detect at low [O 2 ] is all synthesized de novo by an active NO synthase; this suggests that any claim about the physiological relevance of NO generated from NO 2 Ϫ in cells, tissues, or in vivo should be reevaluated in relation to the present evidence. Ϫ to NO by hemoglobin or by any of the other mechanisms proposed (47, 48) .
Experimental Procedures
Reagents. Cell culture medium, hygromycin B, and trypsin-EDTA were purchased from Invitrogen. All other reagents were purchased from Sigma-Aldrich except blasticidin, which was obtained from Calbiochem.
Cell Culture and Induction of Human NOS in Tet-iNOS-293 Cells. The tetracycline-inducible human embryonic kidney cell line TetiNOS-293, which stably expresses the NOS from human chondrocytes, was obtained as described in ref. 33 . Maximal expression of NOS in Tet-iNOS-293 cells was achieved by 15 h incubation with induction medium (DMEM, 10% HI-FBS, 1.5 g⅐ml Ϫ1 tetracycline, and 500 M S-EITU). Induced cells were harvested and counted as described in ref. 31 , then placed in a water bath at 37°C before measurement in the visible light spectroscopy (VLS) chamber.
Simultaneous Measurement of Cytochrome Redox States, [O2], and
[NO] Generated from Exogenous L-Arginine During Cellular Respiration. The VLS system was the same as described in refs. 29-31. In brief, measured changes in optical attenuation were converted into changes in the redox states of the mitochondrial cytochromes by two multiwavelength linear least-squares fits of their specific absorption coefficients (29) . A first-order background was included in the least-squares fitting algorithm to account for nonabsorption changes (31) . Calibration and operation of the Clark-type O 2 electrode (Rank Brothers) and the NO electrode (amiNO-700, Innovative Instruments) have also been described (29) (30) (31) .
The absorption spectrum of cytochrome c oxidase is a combination of the spectra of cytochrome a (heme a) and cytochrome a 3 (heme a 3 ), with the major contribution (80-90%) coming from cytochrome a (29) . For convenience, we refer to the measurement of the redox state of cytochromes aa 3 as the redox state of cytochrome c oxidase, which is expressed as a percentage change from the steady state at initial high [O 2 ] to that at hypoxia. When the enzyme is in turnover and [O 2 ] is not affecting its steady state, the catalytic center of cytochrome c oxidase (cytochrome a 3 -Cu B ) is mainly populated by the oxidized species (O, P, and F). We refer to this situation as cytochrome c oxidase being oxidized or in its oxidized state. As cells respire toward hypoxia, the enzyme becomes more and more reduced as the catalytic center is increasingly populated by reduced species E and R until cytochromes aa 3 reach maximal reduction, as is found when dithionite is added to the purified preparation of cytochrome c oxidase. Furthermore, any disturbance in the catalytic center of cytochrome c oxidase, such as inhibition of electron turnover, will consequently increase the accumulation of electrons in cytochrome a and produce an increase in its reduced form, as is observed at hypoxia (31) . We refer to both these situations, an accumulation of electrons at cytochrome a or an increase in reduced species at the catalytic center, as cytochrome c oxidase becoming more reduced. (37, 38, 49) .
Formation of Nitrite Inside the VLS Chamber. The formation of nitrite from the addition of L-arginine to cells respiring in the VLS chamber was measured by extracting 10 l of cell suspension at the beginning and at the end of the respiration trace and injecting them into a second chamber fitted with an amiNO-700 NO sensor and containing 10 mM KI and 100 mM H 2 SO 4 . The nitrite concentration was calculated by comparing the observed change in current with that of a nitrite standard.
Measurement of cGMP. cGMP activity was measured by enzyme immunoassay system for intracellular cGMP, according to the manufacturer's instructions (Amersham Bioscience). Cell samples (5 l; Ϸ0.8 ϫ 10 5 cells) were taken from the VLS chamber and further diluted with 500 l of lysing reagent. Values of cGMP were normalized to the cell number of each sample in the VLS chamber and expressed as picomoles per 10 7 cells.
Release of NO from DETA-NO. DETA-NO (37.5, 75, and 150 M) was used to generate NO. In the absence of cells, these concentrations of DETA-NO released Ϸ70, 260, and 565 nM NO, respectively, in the VLS medium over a period of 5 min. Noninduced cells were then incubated in the chamber for 5 min with each concentration of DETA-NO, the chamber was closed, and the cells were allowed to respire toward hypoxia. In some of these experiments KCN was administered at 70 M O 2 and the release of NO was monitored. 
